4//SEC Filing
Morrison Scott W 4
Accession 0001819790-24-000113
CIK 0001819790other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 5:52 PM ET
Size
6.9 KB
Accession
0001819790-24-000113
Insider Transaction Report
Form 4
Morrison Scott W
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-15+1,333→ 6,016 total - Exercise/Conversion
Restricted Stock Units
2024-09-15−1,333→ 1,334 total→ Common Stock (1,333 underlying)
Footnotes (2)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]The RSUs vest in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001662426
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 5:52 PM ET
- Size
- 6.9 KB